NRAS and melanoma: For example, it is well established that activation of the mitogen‐activated protein kinase (MAPK) pathway is critical for melanoma development, with the mutation of genes such as BRAF, NRAS and NF1 defining around three‐quarters of non‐acral cutaneous melanoma cases [17].